What's new

Human medicines European public assessment report (EPAR): Tafinlar, dabrafenib, Date of authorisation: 26/08/2013, Revision: 36, Status: Authorised

Human medicines European public assessment report (EPAR): Tafinlar, dabrafenib, Date of authorisation: 26/08/2013, Revision: 36, Status: Authorised

Jun 17, 2025 - 16:25
 0
Human medicines European public assessment report (EPAR): Tafinlar, dabrafenib, Date of authorisation: 26/08/2013, Revision: 36, Status: Authorised
Human medicines European public assessment report (EPAR): Tafinlar, dabrafenib, Date of authorisation: 26/08/2013, Revision: 36, Status: Authorised
Read More

Tags:

Previous Article

Human medicines European public assessment report (EPAR): Tyenne, tocilizumab, D...

Next Article

Human medicines European public assessment report (EPAR): Tecentriq, atezolizuma...

Related Posts

Human medicines European public assessment report (EPAR): Cubicin, daptomycin, Date of authorisation: 19/01/2006, Revision: 40, Status: Authorised

Human medicines European public assessment report (EPAR...

May 28, 2025  0

Human medicines European public assessment report (EPAR): Imuldosa, ustekinumab, Date of authorisation: 12/12/2024, Revision: 1, Status: Authorised

Human medicines European public assessment report (EPAR...

Jun 6, 2025  0

EMEA-002474-PIP02-18-M02

EMEA-002474-PIP02-18-M02

Jun 16, 2025  0